Department of Medical Pharmacology, Consiglio Nazionale delle Ricerche, Institute of Neuroscience, Cellular and Molecular Pharmacology Center, University of Milan, 20129 Milan, Italy.
J Neurosci. 2010 Apr 14;30(15):5311-25. doi: 10.1523/JNEUROSCI.5095-09.2010.
alpha6* nicotinic acetylcholine receptors (nAChRs) are highly and selectively expressed by mesostriatal dopamine (DA) neurons. These neurons are thought to mediate several behavioral effects of nicotine, including locomotion, habit learning, and reinforcement. Yet the functional role of alpha6* nAChRs in midbrain DA neurons is mostly unknown. The aim of this study was to determine the composition and in vivo functional role of alpha6* nAChR in mesolimbic DA neurons of male rats. Immunoprecipitation and immunopurification techniques coupled with cell-specific lesions showed that the composition of alpha6* nAChR in the mesostriatal system is heterogeneous, with (non-alpha4)alpha6beta2* being predominant in the mesolimbic pathway and alpha4alpha6beta2* in the nigrostriatal pathway. We verified whether alpha6* receptors mediate the systemic effects of nicotine on the mesolimbic DA pathway by perfusing the selective antagonists alpha-conotoxin MII (CntxMII) (alpha3/alpha6beta2* selective) or alpha-conotoxin PIA (CntxPIA) (alpha6beta2* selective) into ventral tegmental area (VTA). The intra-VTA perfusion of CntxMII or CntxPIA markedly decreased systemic nicotine-elicited DA release in the nucleus accumbens and habituated locomotion; the intra-VTA perfusion of CntxMII also decreased the rate of nicotine infusion in the maintenance phase of nicotine, but not of food, self-administration. Overall, the results of these experiments show that the alpha6beta2* nAChRs expressed in the VTA are necessary for the effects of systemic nicotine on DA neuron activity and DA-dependent behaviors such as locomotion and reinforcement, and suggest that alpha6beta2*-selective compounds capable of crossing the blood-brain barrier may affect the addictive properties of nicotine and therefore be useful in the treatment of tobacco dependence.
α6* 型烟碱型乙酰胆碱受体 (nAChRs) 在中脑多巴胺 (DA) 神经元中高度且选择性地表达。这些神经元被认为介导尼古丁的几种行为效应,包括运动、习惯学习和强化。然而,α6* nAChRs 在中脑 DA 神经元中的功能作用在很大程度上尚不清楚。本研究的目的是确定雄性大鼠中脑边缘 DA 神经元中 α6* nAChR 的组成和体内功能作用。免疫沉淀和免疫纯化技术与细胞特异性损伤相结合表明,中脑边缘系统中 α6* nAChR 的组成是异质的,(非-α4)α6β2* 在中脑边缘通路中占优势,而 α4α6β2* 在黑质纹状体通路中占优势。我们通过将选择性拮抗剂 α-芋螺毒素 MII (CntxMII)(α3/α6β2* 选择性)或 α-芋螺毒素 PIA (CntxPIA)(α6β2* 选择性)灌注到腹侧被盖区 (VTA) 来验证 α6* 受体是否介导尼古丁对中脑边缘 DA 通路的全身作用。VTA 内灌注 CntxMII 或 CntxPIA 可显著降低伏隔核中系统性尼古丁引起的 DA 释放和习惯运动;VTA 内灌注 CntxMII 也降低了尼古丁维持阶段的输注率,但不影响食物的自我给药。总体而言,这些实验的结果表明,VTA 中表达的 α6β2* nAChRs 对于系统性尼古丁对 DA 神经元活性和 DA 依赖性行为(如运动和强化)的影响是必要的,并表明能够穿过血脑屏障的α6β2*-选择性化合物可能会影响尼古丁的成瘾性,因此在治疗烟草依赖方面可能有用。